BlackRock’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.5M | Buy |
2,229,133
+233,232
| +12% | +$1.1M | ﹤0.01% | 3337 |
|
|
2025
Q1 | $7.29M | Sell |
1,995,901
-33,307
| -2% | -$122K | ﹤0.01% | 3437 |
|
|
2024
Q4 | $9.58M | Buy |
2,029,208
+217,906
| +12% | +$1.03M | ﹤0.01% | 3412 |
|
|
2024
Q3 | $16.9M | Buy |
1,811,302
+265,233
| +17% | +$2.47M | ﹤0.01% | 3107 |
|
|
2024
Q2 | $8.89M | Buy |
1,546,069
+230,698
| +18% | +$1.33M | ﹤0.01% | 3392 |
|
|
2024
Q1 | $8.83M | Buy |
1,315,371
+9,503
| +0.7% | +$63.8K | ﹤0.01% | 3354 |
|
|
2023
Q4 | $8.42M | Sell |
1,305,868
-85,890
| -6% | -$554K | ﹤0.01% | 3411 |
|
|
2023
Q3 | $6.96M | Sell |
1,391,758
-63,681
| -4% | -$318K | ﹤0.01% | 3467 |
|
|
2023
Q2 | $10.2M | Buy |
1,455,439
+212,919
| +17% | +$1.5M | ﹤0.01% | 3338 |
|
|
2023
Q1 | $7.7M | Sell |
1,242,520
-7,508
| -0.6% | -$46.6K | ﹤0.01% | 3382 |
|
|
2022
Q4 | $7.98M | Buy |
1,250,028
+192,850
| +18% | +$1.23M | ﹤0.01% | 3432 |
|
|
2022
Q3 | $9.07M | Sell |
1,057,178
-26,496
| -2% | -$227K | ﹤0.01% | 3412 |
|
|
2022
Q2 | $14.7M | Sell |
1,083,674
-32,960
| -3% | -$448K | ﹤0.01% | 3197 |
|
|
2022
Q1 | $17M | Sell |
1,116,634
-31,339
| -3% | -$477K | ﹤0.01% | 3205 |
|
|
2021
Q4 | $26.3M | Buy |
1,147,973
+28,288
| +3% | +$647K | ﹤0.01% | 3059 |
|
|
2021
Q3 | $15.6M | Buy |
1,119,685
+25,825
| +2% | +$360K | ﹤0.01% | 3389 |
|
|
2021
Q2 | $11.7M | Buy |
1,093,860
+661,735
| +153% | +$7.06M | ﹤0.01% | 3528 |
|
|
2021
Q1 | $5.7M | Sell |
432,125
-240,079
| -36% | -$3.16M | ﹤0.01% | 3819 |
|
|
2020
Q4 | $13.6M | Buy |
+672,204
| New | +$13.6M | ﹤0.01% | 3146 |
|